Value-of-information analysis to guide future research in the management of the colorectal malignant polyp

Diseases of the Colon and Rectum

Volumn 53, Issue 2, 2010, Pages 135-142

  Hassan, Cesare ^a   Pickhardt, Perry J ^b,c   Di Giulio, Emilio ^a   Hunink, Myriam G M ^d,e   Zullo, Angelo ^a   Nardelli, Bruno Buongiorno ^f  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f CNR   (Italy)

Author keywords

Colorectal cancer; Colorectal malignant polyp; Colorectal polyp with cancer; Cost effectiveness; Decision analysis; Histopathology inaccuracy

Indexed keywords

ARTICLE; CANCER MORTALITY; CLINICAL PRACTICE; CLINICAL RESEARCH; COLON POLYP; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC ERROR; ENDOSCOPIC POLYPECTOMY; ENDOSCOPIC SURGERY; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; INFORMATION; INTERMETHOD COMPARISON; LIFE EXPECTANCY; MODEL; PRACTICE GUIDELINE; PROBABILITY; RECTUM POLYP; WATCHFUL WAITING; AGED; COLONOSCOPY; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; MEDICAL RESEARCH; METHODOLOGY; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; STANDARD; STATISTICS; TREATMENT OUTCOME;

AGED; BIOMEDICAL RESEARCH; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION MAKING; GUIDELINES AS TOPIC; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; ROC CURVE; TREATMENT OUTCOME;

EID: 77449127457     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181c3be55     Document Type: Article

References (34)

1. Hermanek P, Fruhmorgen P, Guggenmoos-Holzmann I, Altendorf A, Matek W. The malignant potential of colorectal polyps: a new statistical approach. Endoscopy. 1983;15:16-20.
2. Chantereau MJ, Faivre J, Boutron MC, et al. Epidemiology, management, and prognosis of malignant large bowel polyps within a defined population. Gut. 1992;33:259-263.
3. Minamoto T, Mai M, Ogino T, et al. Early invasive colorectalcarcinomas metastatic to the lymph node with attention to their nonpolypoid development. Am J Gastroenterol. 1993;88: 1035-1039.
4. Alves A, Panis Y, Mantion G, Slim K, Kwiatkowski F, Vicaut E. The AFC score: validation of a 4-item predicting score of postoperative mortality after colorectal resection for cancer or diverticulitis: results of a prospective multicenter study in 1049 patients. Ann Surg. 2007;246:91-96.
5. National Cancer Institute. Surveillance Epidemiology and End Results: Cancer Statistics: Fast Stats. http://seer.cancer.gov/faststats/. Accessed September 15, 2008.
6. Morson BC, Bussey HJ, Samoorian S. Policy of local excision for early cancer of the colorectum. Gut. 1977;18:1045-1050.
7. Cranley JP, Petras RE, Carey WD, Paradis K, Sivak MV. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology. 1986; 91:419-427.
8. Netzer P, Forster C, Biral R, et al. Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut. 1998; 43:669-674.
9. Jass JR. Malignant colorectal polyps. Gastroenterology. 1995;109: 2034-2035.
10. Williams B, Saunders BP. The rationale for current practice in the management of malignant colonic polyps. Endoscopy. 1993; 25:469-474.
11. Riddell RH. Hands off "cancerous" large bowel polyps. Gastroenterology. 1985;89:432-435.
12. Komuta K, Batts K, Jessurun J, et al. Interobserver variability in the pathological assessment of malignant colorectal polyps. Br J Surg. 2004;91:1479-1484.
13. Cooper HS, Deppisch LM, Gourley WK, et al. Endoscopically removed malignant colorectal polyps: clinico-pathological correlations. Gastroenterology. 1995;108:1657-1665.
14. Wilcox GM, Beck JR. Early invasive cancer in adenomatous colonic polyps ("malignant polyps"): evaluation of the therapeutic options by decision analysis. Gastroenterology. 1987;92: 1159-1168.
15. Hunink MG. Decision making in the face of uncertainty and resource constraints: examples from trauma imaging. Radiology. 2005;235:375-383.
16. Groot Koerkamp B, Nikken JJ, Oei EH, Stijnen T, Ginai AZ, Hunink MG. Value of information analysis used to determine the necessity of additional research: MR imaging in acute knee trauma as an example. Radiology. 2008;246:420-425.
17. Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics. 2006;24:1055-1068.
18. Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum. 2005;48:1588-1596.
19. Life Tables. Vital Statistics of the United States. Preprint of Volume II, Mortality, Part A, Section 6. Hyattsville, MD: National Center for Health Statistics; 1998.
20. US Department of Health and Human Services. Centers for Medicare and Medicaid Services. Physician Fee Schedule Lookup: Overview. http://www.cms.hhs. gov/pfslookup. Accessed September 15, 2008.
21. Tengs TO, Wallace A. One thousand health-related quality-oflife estimates. Med Care. 2000;38:583-637.
22. US Department of Labor. Bureau of Labor Statistics. Consumer price index for all urban consumers (CPI-U), US city average, medical care. www. bls.gov/cpi/home.htm. Accessed September 14, 2008.
23. Felli JC, Hazen GB. Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998;18:95-109.
24. Hunink MGM, Glasziou P. Decision Making in Health and Medicine. Cambridge, UK: Cambridge University Press; 2001.
25. Seeff LC, Manninen DL, Dong FB, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004;127:1661-1669.
26. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169-174.
27. Waye JD, Haggitt RC. Controversies, dilemmas, and dialogues: when is colonoscopic resection of an adenomatous polyp containing a " malignancy" sufficient? Am J Gastroenterol. 1990;85: 1564-1568.
28. Volk EE, Goldblum JR, Petras RE, Carey WD, Fazio VW. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology. 1995;109:1801-1807.
29. Wilcox GM, Anderson PB, Colacchio TA. Early invasive carcinoma in colonic polyps: a review of the literature with emphasis on the assessment of the risk of metastasis. Cancer. 1986;57: 160-171.
30. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006;130:1865-1871. (Pubitemid 43668858)
31. Hassan C, Pickhardt PJ, Laghi A, et al. CT colonography to screen for colorectal cancer, extracolonic cancer, and aortic aneurysm: model simulation with cost-effectiveness analysis. Arch Intern Med. 2008;168:696-705.
32. Hassan C, Di Giulio E, Pickhardt PJ, et al. Cost effectiveness of colonoscopy, based on the appropriateness of an indication. Clin Gastroenterol Hepatol. 2008;6:1231-1236.
33. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung cancer screening with helical computed tomography in older adult smokers. JAMA. 2003;289:313-322.
34. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137:96-104. (Pubitemid 34779153)